Zobrazeno 1 - 10
of 182
pro vyhledávání: '"Suzanne L Baker"'
Publikováno v:
eLife, Vol 8 (2019)
Tau pathology first appears in the transentorhinal and anterolateral entorhinal cortex (alEC) in the aging brain. The transition to Alzheimer’s disease (AD) is hypothesized to involve amyloid-β (Aβ) facilitated tau spread through neural connectio
Externí odkaz:
https://doaj.org/article/64bd885a74f94b44b48dc38832189b46
Autor:
Orit H Lesman-Segev, Renaud La Joie, Melanie L Stephens, Ida Sonni, Richard Tsai, Viktoriya Bourakova, Adrienne V Visani, Lauren Edwards, James P O'Neil, Suzanne L Baker, Raquel C Gardner, MD, Mustafa Janabi, Kiran Chaudhary, David C Perry, Joel H Kramer, Bruce L Miller, William J Jagust, Gil D Rabinovici
Publikováno v:
NeuroImage: Clinical, Vol 24, Iss , Pp - (2019)
Objective: To characterize individual and group-level neuroimaging findings in patients at risk for Chronic Traumatic Encephalopathy (CTE). Methods: Eleven male patients meeting criteria for Traumatic Encephalopathy Syndrome (TES, median age: 64) und
Externí odkaz:
https://doaj.org/article/104d8e061036467790c610c87f2962e4
Autor:
Samuel N Lockhart, Suzanne L Baker, Nobuyuki Okamura, Katsutoshi Furukawa, Aiko Ishiki, Shozo Furumoto, Manabu Tashiro, Kazuhiko Yanai, Hiroyuki Arai, Yukitsuka Kudo, Ryuichi Harada, Naoki Tomita, Kotaro Hiraoka, Shoichi Watanuki, William J Jagust
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0158460 (2016)
[18F]THK5351, a recently-developed positron emission tomography (PET) tracer for measuring tau neurofibrillary tangle accumulation, may help researchers examine aging, disease, and tau pathology in living human brains. We examined THK5351 tracer phar
Externí odkaz:
https://doaj.org/article/de3b40b692504cc5bbdcf8deaa24a799
Autor:
Theresa M. Harrison, Tyler J. Ward, Alice Murphy, Suzanne L. Baker, Pablo A. Dominguez, Robert Koeppe, Prashanthi Vemuri, Samuel N. Lockhart, Youngkyoo Jung, Danielle J. Harvey, Laura Lovato, Arthur W. Toga, Joseph Masdeu, Hwamee Oh, Darren R. Gitelman, Neelum Aggarwal, Heather M. Snyder, Laura D. Baker, Charles DeCarli, William J. Jagust, Susan M. Landau
Publikováno v:
NeuroImage, Vol 265, Iss , Pp 119761- (2023)
Accurate measurement of Alzheimer's disease (AD) pathology in older adults without significant clinical impairment is critical to assessing intervention strategies aimed at slowing AD-related cognitive decline. The U.S. Study to Protect Brain Health
Externí odkaz:
https://doaj.org/article/a0f290d012c6415f8163be639455f5c6
Autor:
Edmond Teng, Paul T. Manser, Sandra Sanabria Bohorquez, Kristin R. Wildsmith, Karen Pickthorn, Suzanne L. Baker, Michael Ward, Geoffrey A. Kerchner, Robby M. Weimer
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-14 (2021)
Abstract Background The role and implementation of tau PET imaging for predicting subsequent cognitive decline in Alzheimer’s disease (AD) remains uncertain. This study was designed to evaluate the relationship between baseline [18F]GTP1 tau PET an
Externí odkaz:
https://doaj.org/article/151ea849eff2427ead44ea9980aa2f28
Autor:
Theresa M. Harrison, Anne Maass, Jenna N. Adams, Richard Du, Suzanne L. Baker, William J. Jagust
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
Deposition of tau protein aggregates occurs during aging and Alzheimer disease. Here, the authors show that tau burden in the anterior-temporal memory network is associated with disrupted fMRI connectivity and functional isolation of the hippocampus
Externí odkaz:
https://doaj.org/article/943d6b83e00c49b4bc60134224b62d84
Autor:
Lindsey Dobyns, Kailin Zhuang, Suzanne L. Baker, Dan Mungas, William J. Jagust, Theresa M. Harrison
Publikováno v:
Nature Aging. 3:229-237
Autor:
Ida Sonni, Orit H. Lesman Segev, Suzanne L. Baker, Leonardo Iaccarino, Deniz Korman, Gil D. Rabinovici, William J. Jagust, Susan M. Landau, Renaud La Joie, for the Alzheimer's Disease Neuroimaging Initiative
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 12, Iss 1, Pp n/a-n/a (2020)
Abstract Introduction Positron emission tomography targeting tau (tau‐PET) is a promising diagnostic tool for the identification of Alzheimer's disease (AD). Currently available data rely on quantitative measures, and a visual interpretation method
Externí odkaz:
https://doaj.org/article/c7f218404cb64730a9c4c0082d85af83
Autor:
Cécile Tissot, Stijn Servaes, Firoza Z. Lussier, João Pedro Ferrari-Souza, Joseph Therriault, Pâmela C.L. Ferreira, Gleb Bezgin, Bruna Bellaver, Douglas Teixeira Leffa, Sulantha S. Mathotaarachchi, Mira Chamoun, Jenna Stevenson, Nesrine Rahmouni, Min Su Kang, Vanessa Pallen, Nina Margherita-Poltronetti, Yi-Ting Wang, Jaime Fernandez-Arias, Andrea L. Benedet, Eduardo R. Zimmer, Jean-Paul Soucy, Dana L. Tudorascu, Annie D. Cohen, Madeleine Sharp, Serge Gauthier, Gassan Massarweh, Brian Lopresti, William E. Klunk, Suzanne L. Baker, Victor L. Villemagne, Pedro Rosa-Neto, Tharick A. Pascoal
Publikováno v:
Journal of Nuclear Medicine. 64:452-459
Autor:
Kristin R. Wildsmith, Geoffrey A. Kerchner, Michael Ward, Edmond Teng, Paul T. Manser, Suzanne L. Baker, Karen Pickthorn, Sandra Sanabria Bohorquez, Robby M. Weimer
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-14 (2021)
Alzheimer's research & therapy, vol 13, iss 1
Alzheimer's Research & Therapy
Alzheimer's research & therapy, vol 13, iss 1
Alzheimer's Research & Therapy
Background The role and implementation of tau PET imaging for predicting subsequent cognitive decline in Alzheimer’s disease (AD) remains uncertain. This study was designed to evaluate the relationship between baseline [18F]GTP1 tau PET and subsequ